Skip to main content
. 2018 Oct 11;6(6):957–965. doi: 10.1002/mgg3.464

Table 1.

Characteristics of patients with BRCA1/2 mutation by their satisfaction or not with the involvement of their GP in their specific follow‐up care (n = 176)

Characteristics Answers Unsatisfied n = 43(%) Satisfied n = 132 (%) Total N p [Link]
Personal history of cancer Yes 24 (55.8) 77 (58.3) 101 0.77
No 19 (44.2) 55 (41.7) 74
GP consultation before geneticist Yes 3 (7) 43 (32.5) 46 0.0009
No 40 (93) 89 (67.5) 129
Ability of GP to answer BRCA1/2‐specific questions from patients 1‐Not at all 23 (60.5) 22 (18.2) 45 0.0001
2‐A little
3‐Moderately 11 (29) 40 (33) 51
4‐Sufficiently 4 (10.5) 59 (48.8) 63
5‐Completely
Personal research Yes 29 (67.4) 52 (39.7) 81 0.0016
No 14 (32.5) 79 (60.3) 93
GPs should provide psychological support before disclosure of the results 1‐Totally disagree 35 (81.4) 95 (72) 130 0.26
2‐Somewhat disagree
3‐Neither agree nor disagree 4 (9.3) 19 (14.4) 23
4‐Rather agree 4 (9.3) 18 (13.6) 22
5‐Totally agree
Possibility to ask the geneticist about BRCA1/2 care and follow‐up questions Yes 33 (76.7) 114 (86.4) 147 0.09
No 9 (21) 16 (12.1) 25
Practitioner responsible for strategy option (breast screening or surgery) Oncogeneticist 35 (94.6) 74 (66.7) 109 0.0032
GP 2(5.4) 37 (33.3) 39
Practitioner responsible for breast surveillance GP 1 (2.3) 32 (24.4) 33 0.0016
Gynecologist 41 (97.7) 99 (75.6) 140
Oncologist
Oncogeneticist
Radiologist
No one

Any questionnaire answered, even incomplete was considered.

GP: general practitioner.

p < 0.05 by chi‐square or Fisher exact test.